Influence of Race, Ethnicity, and Nativity on Distribution and Outcomes Among Women With Choriocarcinoma in Florida

IntroductionWhile race/ethnicity are established factors of risk and outcomes for multiple cancers in women, nativity may more precisely estimate cancer risk and survival. The role of nativity in choriocarcinoma, a form of gestational trophoblastic neoplasia arising from the placenta, is unexplored. Our objective was to examine how race, ethnicity, and nativity influence disease presentation and survival in women with choriocarcinoma in Florida.MethodsUsing the Florida Cancer Data System (FCDS), we identified women diagnosed with choriocarcinoma from 1981-2020. Clinicodemographic data were extracted, including nativity (US-born/Non-US-born). Statistical analyses included chi-square, Cox proportional hazards models, and Kaplan-Meier method, with significance set at <i>P</i> < 0.05.Results262 eligible patients were included. Black women more frequently presented with distant disease vs White women (63.8% vs 46.2%, <i>P</i> = 0.05). Non-US-Born women were older at diagnosis than US-born (32.8 vs 26.7 years, <i>P</i> < 0.01) and received fewer surgical and radiation treatments (<i>P</i> < 0.05). Nativity, ethnicity, and race were not associated with overall survival (OS) (all <i>P</i> > 0.05). Multivariable analyses adjusted for race and birthplace showed increasing age (HR 1.05 [1.02-1.09], <i>P</i> = 0.023) and surgical treatment (HR 0.28 [0.09-0.79], <i>P</i> = 0.016) were associated with OS. Despite favorable OS, survival curves diverged after initial treatment, favoring White over Black patients, and Hispanic over Non-Hispanic patients, though neither were statistically significant (<i>P</i> > 0.05).ConclusionRace and nativity are associated with variations in choriocarcinoma presentation and treatment course but do not affect survival. Race and ethnicity may predict post-treatment, long-term survival, though whether this reflects choriocarcinoma biology or broader disparities remain unclear.